The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate of 48 percent.
Ebola vaccine triggers cross reactive T cells against Bundibugyo ebolavirus
- Post author:admin
- Post published:
- Post category:uncategorized